Work

Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?

Year: 2022
Type: editorial
Abstract: While there has been substantial progress and notable achievements in the use of adeno-associated virus (AAV) gene therapy vectors for treatment of rare diseases, setbacks related to vector toxicit...
Language: English
Subfield: Genetics
Open Access status: bronze
OpenAlex ID: W4225772001
Cites: 28
Cited by: 165
Related to: 10